Citations

Mayo Clinic

Clear

2818 citation(s) found for "C, Liu".

Circulating Tumor DNA As a Biomarker for Molecular Residual Disease Assessment in Patients with Diffuse Large B-Cell Lymphoma
Narkhede, Mayur , LaBarbera, Katie , Widden, Hayley, Benrud, Ryan, Kalashnikova, Ekaterina, Malashevich, Allyson Koyen , Liu, Minetta C. , Aleshin, Alexey , Tomassetti, Sarah , Iqbal, Madiha , LaBarbera, Katie, Rathore, Richa , Kalashnikova, Ekaterina

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11884-11886

10.1182/blood-2022-169656 Get It

Autologous Hematopoietic Cell Transplant Consolidation for First Response Is Associated with Longer Survival in Patients with Nodal Peripheral T-Cell Lymphoma
Rose, Ashley , Eatrides, Jennifer , Lazaryan, Aleksandr , Ibarz, Javier Pinilla, Liu, Hien , Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, Sokol, Lubomir , Zhang, Yumeng , Saeed, Hayder , Shah, Bijal , Khimani, Farhad , Locke, Frederick L. , Jain, Michael D. , Kim, Jongphil , Zhang, Ling , Nishihori, Taiga , Sokol, Lubomir

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6569-6570

10.1182/blood-2022-168347 Get It

Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry
Terebelo, Howard R. , Abonour, Rafat , Durie, Brian G.M. , Omel, James L., Narang, Mohit , Toomey, Kathleen, Rifkin, Robert M. , Gasparetto, Cristina, Yu, Edward, Anand, Jasmeet, Liu, Liang , Jou, Ying‐Ming, Jagannath, Sundar, Richter, Joshua , Ailawadhi, Sikander , Lee, Hans C. , Hardin, James W. , Wagner, Lynne I. , Omel, James, Gasparetto, Cristina , Jagannath, Sundar

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8089-8091

10.1182/blood-2022-158627 Get It

Comparing Survival Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Nodal Peripheral T-Cell Lymphoma
Eatrides, Jennifer , Lazaryan, Aleksandr , Liu, Hien , Ibarz, Javier Pinilla, Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, Sokol, Lubomir , Zhang, Yumeng , Rose, Ashley M. , Zhang, Ling , Khimani, Farhad , Shah, Bijal , Saeed, Hayder , Jain, Michael D. , Locke, Frederick L. , Kim, Jongphil , Sokol, Lubomir , Nishihori, Taiga

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10634-10636

10.1182/blood-2022-169200 Get It

TET2 Down-Regulation Confers Bortezomib Resistance in Multiple Myeloma
Liu, Xiaobo , Yang, Ting , Kumar, Shaji , Jin, Fengyan, Dai, Yun , Jin, Fengyan

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4185-4186

10.1182/blood-2022-168239 Get It

Successful cardiac resynchronization therapy by left bundle branch area pacing through a chronically occluded left subclavian system with limited vascular access preventing coronary sinus lead implant
Liu, Xiaoke

Pacing and Clinical Electrophysiology | November 25, 2022 | Volume: 46 | Issue: 7 | Pages: 701-704

10.1111/pace.14633 | PMID 36427357 Get It

AbstractBackgroundConventional cardiac resynchronization therapy (CRT) involves implantation of a coronary sinus pacing lead through a delivery sheath, which typically requires a large venous access through a safe sheath of 9 French or greater in size. In patients who have very limited access due to scar tissue from previous implants or critical venous stenosis/closure, such large caliber access may not be available.Methods and ResultsWe report a case of CRT procedure in an 84‐year‐old male with a previous history of ischemic dilated cardiomyopathy (ejection fraction 40%) who was dependent on right ventricular pacing with worsening heart failure symptoms. The patient was incidentally discovered to have chronic total closure (CTO) of the left subclavian vein during the procedure. Although the CTO was crossed by a wire and dilated, the venous access was limited to a 7 French sheath which rendered conventional CRT through coronary sinus lead implant impossible. However, using the left bundle branch area pacing (LBBAP) technique which requires a smaller venous access, we were able to successfully achieve CRT. Postprocedure, the patient's paced QRS duration narrowed from 198 to 130 ms. His heart failure symptoms improved, and ejection fraction increased to 45% one‐month after the procedure.ConclusionsIn patients with vascular access limited to a small caliber sheath not suitable for conventional CRT, LBBAP may help achieve procedural success and improve clinical outcome.
Identification of motifs and mechanisms for lipid droplet targeting of the lipolytic inhibitors G0S2 and HIG2
Campbell, Latoya E., Anderson, Aaron , Chen, Yongbin , Johnson, S. M. , McMahon, Cailin E., Liu, Jun , Anderson, Aaron M, Johnson, Scott M, Liu, Jun

Journal of Cell Science | November 24, 2022 | Volume: 135 | Issue: 24 | Pages: No page available

10.1242/jcs.260236 | PMID 36420951 Get It

ABSTRACT G0S2 and HIG2 are two selective inhibitors of ATGL (also known as PNPLA2), the key enzyme for intracellular lipolysis. Whereas G0S2 regulates triglyceride (TG) mobilization in adipocytes and hepatocytes, HIG2 functions to enhance intracellular TG accumulation under hypoxic conditions. A homologous hydrophobic domain (HD) is shared by G0S2 and HIG2 (also known as HILPDA) for binding to ATGL. However, the determinants of their lipid droplet (LD) localization are unknown. Here, we study how G0S2 and HIG2 are targeted to LDs, and identify both ATGL-independent and -dependent mechanisms. Structural prediction and studies in cells reveal that ATGL-independent localization of G0S2 to both the endoplasmic reticulum (ER) and LDs is mediated by a hairpin structure consisting of two hydrophobic sequences. Positively charged residues in the hinge region play a crucial role in sorting G0S2, which initially localizes to ER, to LDs. Interestingly, the role of these positive charges becomes dispensable when ATGL is co-expressed. In comparison, HIG2, which lacks a similar hairpin structure, is dependent on ATGL for its full LD targeting. Thus, our studies identify specific structural features and mechanisms for mediating accumulation of these two ATGL inhibitors on LDs.
Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index
Hui, Daniel J. , Xiao, Brenda , Irvin, Marguerite R. , Kullo, Iftikhar, Limdi, Nita A. , Liu, Cong , Namjou, Bahram , Puckelwartz, Megan J. , Schaid, Daniel J. , Tiwari, Hemant K., Wei, Wei‐Qi, Ritchie, Marylyn D. , Liu, Cong , Puckelwartz, Megan J , Dikilitas, Ozan , Freimuth, Robert R. , Jarvik, Gail P. , Kottyan, Leah C. , Luo, Yuan , Verma, Shefali S. , Kim, Dokyoon

Biocomputing 2023 | November 24, 2022 | Volume: No volume available | Issue: No issue available | Pages: 437-448

10.1142/9789811270611_0040 Get It